Literature DB >> 15086729

Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India.

C Duttagupta1, S Sengupta, M Roy, D Sengupta, P Bhattacharya, P Laikangbam, S Roy, S Ghosh, R Das.   

Abstract

Muslim women are known to have lower incidences of cervical cancer and/or human papillomavirus (HPV) infection. Here we aim to determine any association that may be present between the oncogenic HPV16/18 infections and abnormal cytological lesions along with demographic and other attributes among Indian Muslim women (n = 478) and compare with the neighboring Hindus (n = 534) from a prospective cohort study. Agewise distribution of both subject-groups is similar. HPV16/18 infection is present in 9.6% Muslims and 7.5% Hindu women. Jointly atypical cells of undetermined significance (a typical cells of undetermined significance) and HPV16/18 are present in seven Muslim and two Hindu women. No high squamous intraepithelial lesions or cervical cancer is detected at the baseline. HPV16/18 infections show trends that varied with age, a nonlinear trend among Muslim women. In Hindu women the prevalence is highest at age < or =24 years, which linearly drops with increasing age. Abnormal cytology increases significantly in both religion-groups with increasing age. The data show that these Indian Muslim women are equally susceptible to HPV16/18 infection and for the development of abnormal cytology. There is a paucity in epidemiological data, which justifies the need to screen women of all religions for cervical cancer (that includes oncogenic HPV testing).

Entities:  

Mesh:

Year:  2004        PMID: 15086729     DOI: 10.1111/j.1048-891X.2004.014213.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

1.  Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.

Authors:  O M Omran; M AlSheeha
Journal:  Pathol Oncol Res       Date:  2014-06-13       Impact factor: 3.201

2.  Prevalence and clinical utility of human papilloma virus genotyping in patients with cervical lesions.

Authors:  Parminder Kaur; Aruna Aggarwal; Madhu Nagpal; Loveena Oberoi; Swati Sharma
Journal:  J Obstet Gynaecol India       Date:  2014-04-12

Review 3.  A systematic review and meta-analysis of risk factors for sexual transmission of HIV in India.

Authors:  Paul Arora; Nico J D Nagelkerke; Prabhat Jha
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

4.  Papillomavirus infection in rural women in southern India.

Authors:  S Franceschi; R Rajkumar; P J F Snijders; A Arslan; C Mahé; M Plummer; R Sankaranarayanan; J Cherian; C J L M Meijer; E Weiderpass
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

5.  Determination and evaluation of HR-HPV genotype in different communities of Bihar, India.

Authors:  Akhtar Parwez; Sunit Singh; Rahul Kumar; Roushan Kumari; Vikas Kumar; Vidyut Prakash; Mohammad Ali
Journal:  Int J Health Sci (Qassim)       Date:  2022 Sep-Oct

6.  HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia.

Authors:  Ghazi Alsbeih; Najla Al-Harbi; Medhat El-Sebaie; Ismail Al-Badawi
Journal:  Infect Agent Cancer       Date:  2013-05-04       Impact factor: 2.965

7.  Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India.

Authors:  M Diaz; J J Kim; G Albero; S de Sanjosé; G Clifford; F X Bosch; S J Goldie
Journal:  Br J Cancer       Date:  2008-07-08       Impact factor: 7.640

8.  Prevalence of human papillomavirus in Indonesia: a population-based study in three regions.

Authors:  J N I Vet; M A de Boer; B E W M van den Akker; B Siregar; S Budiningsih; D Tyasmorowati; S Cornain; A A W Peters; G J Fleuren
Journal:  Br J Cancer       Date:  2008-07-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.